Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CA5B 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
2 CA5B 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
3 CA5B 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
4 CA5B 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
5 ADRA2A 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02076 Brimonidine 2件: 13, 90
6 ADRA2A 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
7 ADRA2B 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02076 Brimonidine 2件: 13, 90
8 ADRA2B 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
9 ADRA2C 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D02076 Brimonidine 2件: 13, 90
10 ADRA2C 2件: cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
11 DDC 9件: Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism D00558 Carbidopa 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201
12 DRD1 10件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
13 DRD2 8件: Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
14 DRD3 2件: Neuroactive ligand-receptor interaction, Dopaminergic synapse D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
15 DRD4 2件: Neuroactive ligand-receptor interaction, Dopaminergic synapse D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
16 DRD5 4件: Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse D00059 Levodopa 8件: 2, 4, 6, 17, 90, 140, 164, 201
17 ABAT 7件: Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
18 CA14 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
19 CA14 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
20 CA14 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
21 CA14 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
22 GAD1 7件: Alanine, aspartate and glutamate metabolism, beta-Alanine metabolism, Taurine and hypotaurine metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse, Type I diabetes mellitus D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
23 GAD2 7件: Alanine, aspartate and glutamate metabolism, beta-Alanine metabolism, Taurine and hypotaurine metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse, Type I diabetes mellitus D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
24 NR3C1 1件: Neuroactive ligand-receptor interaction D00244 Betamethasone 3件: 90, 96, 235
25 NR3C1 1件: Neuroactive ligand-receptor interaction D00292 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
26 NR3C1 1件: Neuroactive ligand-receptor interaction D00385 Triamcinolone 6件: 90, 96, 107, 162, 226, 298
27 NR3C1 1件: Neuroactive ligand-receptor interaction D00972 Betamethasone 3件: 90, 96, 235
28 NR3C1 1件: Neuroactive ligand-receptor interaction D00975 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
29 NR3C1 1件: Neuroactive ligand-receptor interaction D00983 Triamcinolone 6件: 90, 96, 107, 162, 226, 298
30 NR3C1 1件: Neuroactive ligand-receptor interaction D00984 Triamcinolone 6件: 90, 96, 107, 162, 226, 298
31 NR3C1 1件: Neuroactive ligand-receptor interaction D00985 Triamcinolone 6件: 90, 96, 107, 162, 226, 298
32 NR3C1 1件: Neuroactive ligand-receptor interaction D01357 Betamethasone 3件: 90, 96, 235
33 NR3C1 1件: Neuroactive ligand-receptor interaction D01402 Betamethasone 3件: 90, 96, 235
34 NR3C1 1件: Neuroactive ligand-receptor interaction D01510 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
35 NR3C1 1件: Neuroactive ligand-receptor interaction D01615 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
36 NR3C1 1件: Neuroactive ligand-receptor interaction D01632 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
37 NR3C1 1件: Neuroactive ligand-receptor interaction D01637 Betamethasone 3件: 90, 96, 235
38 NR3C1 1件: Neuroactive ligand-receptor interaction D01825 Fluocinolone acetonide 1件: 90
39 NR3C1 1件: Neuroactive ligand-receptor interaction D01948 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
40 NR3C1 1件: Neuroactive ligand-receptor interaction D02032 Betamethasone 3件: 90, 96, 235
41 NR3C1 1件: Neuroactive ligand-receptor interaction D02174 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
42 NR3C1 1件: Neuroactive ligand-receptor interaction D02286 Betamethasone 3件: 90, 96, 235
43 NR3C1 1件: Neuroactive ligand-receptor interaction D02591 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
44 NR3C1 1件: Neuroactive ligand-receptor interaction D02592 Dexamethasone 10件: 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
45 NR3C1 1件: Neuroactive ligand-receptor interaction D06216 Triamcinolone 6件: 90, 96, 107, 162, 226, 298
46 CA13 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
47 CA13 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
48 CA13 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
49 CA13 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
50 MTNR1A 2件: Neuroactive ligand-receptor interaction, Circadian entrainment D08170 Melatonin 12件: 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
51 MTNR1B 2件: Neuroactive ligand-receptor interaction, Circadian entrainment D08170 Melatonin 12件: 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202
52 NGFR 8件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis - multiple species, Neurotrophin signaling pathway, Transcriptional misregulation in cancer D11028 Cenegermin 2件: 53, 90
53 PGF 6件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer D09574 Aflibercept 2件: 90, 166
54 PPP3CA 33件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
55 PPP3CB 33件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
56 PPP3CC 33件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
57 PPP3R1 32件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
58 PPP3R2 32件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
59 PTGFR 3件: Calcium signaling pathway, Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction D08661 Unoprostone 1件: 90
60 RARA 5件: Th17 cell differentiation, Estrogen signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia D06543 Vitamin A 3件: 13, 53, 90
61 RARB 4件: Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer, Gastric cancer D06543 Vitamin A 3件: 13, 53, 90
62 VEGFA 24件: EGFR tyrosine kinase inhibitor resistance, MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Relaxin signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Chemical carcinogenesis - reactive oxygen species, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis, Fluid shear stress and atherosclerosis D09574 Aflibercept 2件: 90, 166
63 VEGFB 9件: MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Relaxin signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Pathways in cancer D09574 Aflibercept 2件: 90, 166
64 CA1 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
65 CA1 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
66 CA1 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
67 CA1 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
68 CA2 7件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
69 CA2 7件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion D00653 Dorzolamide 1件: 90
70 CA2 7件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
71 CA2 7件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion D07871 Dorzolamide 1件: 90
72 CA3 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
73 CA3 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
74 CA3 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
75 CA3 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
76 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
77 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D00653 Dorzolamide 1件: 90
78 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
79 CA4 3件: Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation D07871 Dorzolamide 1件: 90
80 CA5A 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
81 CA5A 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
82 CA5A 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
83 CA5A 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
84 CA6 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
85 CA6 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
86 CA6 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
87 CA6 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
88 CA7 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
89 CA7 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
90 CA7 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
91 CA7 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
92 CA8 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
93 CA8 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
94 CA8 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
95 CA8 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
96 CA9 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
97 CA9 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
98 CA9 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
99 CA9 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
100 CA12 2件: Nitrogen metabolism, Metabolic pathways D00218 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
101 CA12 2件: Nitrogen metabolism, Metabolic pathways D00653 Dorzolamide 1件: 90
102 CA12 2件: Nitrogen metabolism, Metabolic pathways D01196 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230
103 CA12 2件: Nitrogen metabolism, Metabolic pathways D07871 Dorzolamide 1件: 90
104 CACNA1C 34件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy D01908 Nilvadipine 1件: 90
105 CACNA1D 35件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cellular senescence, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Tight junction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Carbohydrate digestion and absorption, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy D01908 Nilvadipine 1件: 90
106 CACNA1F 27件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy D01908 Nilvadipine 1件: 90
107 CACNA1S 27件: MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy D01908 Nilvadipine 1件: 90
108 ALDH5A1 3件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, Metabolic pathways D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
109 PDE5A 3件: Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway D02229 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
110 PDE5A 3件: Purine metabolism, Metabolic pathways, cGMP-PKG signaling pathway D08514 Sildenafil 17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
111 CACNA1I 7件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
112 CACNA1H 7件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331
113 CACNA1G 8件: MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome D00399 Valproic acid 17件: 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331